We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 0.00 | 07:47:54 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/6/2021 07:57 | Wasn't meant to be to him. | babbler | |
10/6/2021 07:56 | Nice timing, 130p is a great price, if institutions weren’t interested the placing would be sub 100p Solid going forward with that funding | ny boy | |
10/6/2021 07:43 | they were 75p just last Friday.. Monday's Proaxsis deal with AZN was the game changer they've done incredibly well to get this away at 130p those on the inside will obviously have been told of the huge potential gla | kalkaar | |
10/6/2021 07:43 | And your conspiracy theory is... | saint in exile | |
10/6/2021 07:42 | Odd reply to Wapper given he is saying the same as you !!! | bertiebingo | |
10/6/2021 07:40 | 7m at 130 given where the price was recently is definitely an excellent result | saint in exile | |
10/6/2021 07:38 | £1.30 is an excellent result. These were 60p last month ffs. Wake up... | babbler | |
10/6/2021 07:32 | There's nothing wrong with placings if companies need the cash. We may see a drop towards 130p short term but this will underpin the price now at almost double the price less than a week ago. Placees must be confident. It's better than selling stakes off in investee companies that have amazing potential to grow. Well done the placing forecasters and well done the traders who got out over £2. I'm in for the big payday. Used to trade a lot and still do with small % of portfolio but I've made much more researching and finding potential multi-baggers like NSCI and just being patient. One day/week/month movements are great to watch and traders are important too for churn. Whatever your views / methods I always like to say good luck to all and well done when you get it right and are happy with your trade. None of us get it right every time.GLAH | wapper | |
10/6/2021 07:31 | Nice. Very happy to support this Management with their brilliant inveatment track record. | the stigologist | |
10/6/2021 07:30 | Smart time to raise funds. I have no problem with that. But then I was holding sub-70p so that brings its own perspective. G. | garth | |
10/6/2021 07:26 | Yep placing | bigberty99 | |
10/6/2021 07:16 | There's that placing. You know, the one that the rampers on here were trying to say was just a figment of imagination. Boiler room alive and well so it seems | terminator101 | |
10/6/2021 07:14 | What a load of Shyte | ammu12 | |
09/6/2021 18:21 | Up to 300p | cjb1971 | |
09/6/2021 18:18 | Back to 200p | 4vik | |
09/6/2021 16:43 | Back to 100p | bigberty99 | |
09/6/2021 16:30 | Great top up time :) | k1ngkonggb | |
09/6/2021 16:29 | Lost all of yesterday's gain. Bloody awful day. | investordave | |
09/6/2021 15:33 | Very encouraging re potential for FDA talks on Pivotal Trial , expedited approval etc | the stigologist | |
09/6/2021 15:13 | Last time PDSB was above 12, NSCI was 73p and PDSB was 112% of mkt cap and NSCI a clear buy as stub was worth -200kAt 200p yesterday it was 35% and the stub worth 19m.Now PDSB is 50%, stub is 11m....looks more rational now to buy back in (as I have been) | bertiebingo | |
09/6/2021 15:11 | Yep same here pal | samsung2020 | |
09/6/2021 15:04 | Either way, I'm sticking with my investment for now but I won't pretend that owning shares in NSCI isn't frustrating at times. | investordave |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions